Parmax Pharma Ltd witnessed significant insider trading activity on August 29, 2026, with eleven members of the promoter group acquiring shares. These purchases totaled 83.24 million INR, reflecting a unified buying trend among leadership. No sales occurred during this period, and the company has not recently disclosed an earnings report.